CHARACTERIZATION OF THE GAMMA HERPES VIRUS HV68 V CYCLIN
CHARACTERIZATION OF THE GAMMA HERPES VIRUS HV68 V CYCLIN
批准号:
7349160
负责人:
SAMUEL H SPECK
金额:
$4.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-09 至 2007-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This research investigates the mechanisms by which cyclin homologs encoded by g-herpesviruses (v-cyclin) contribute to gammaherpesvirus pathogenesis and latency. The human gammaherpesviruses, KSHV and EBV, are important causes of cancer, especially in immunocompromised individuals. Because of the specificity of these viruses, in vivo studies of the pathogenesis have been limited. We and others have been developing a small animal model system, infection of inbred mice with gHV68, for analysis of the pathogenesis of gammaherpesvirus infection and the role of individual gammaherpesvirus genes in latency and tumor induction. gHV68 infection is associated with the development of lymphoma and lymphoproliferative disease, severe vasculitis of the great elastic vessels and splenic fibrosis. Studies to date indicate that gHV68 share pathogenetic mechanisms with EBV, KSHV and HVS, validating it as a model for analysis of important questions in gammaherpesvirus pathogenesis. This work is focused on the role of the gHV68 v-cyclin in disease pathogenesis. Notably, the g2-herpesvirus (HVS, KSHV and gHV68) all encode homologs of D-type cyclins, while EBV infection up regulates expression of host d-type cyclins. We have shown that the gHV68 v-cyclin is an oncogene that promotes cell cycle progression in primary lymphocytes and that a gHV68 v-cyclin mutant reacts inefficiently from latently infected MM and or B cells. These observations lead to the following 3 specific aims. Aim 1. Determine the role(s) of the gHV68 v-cyclin in latency and reactivation. Aim 2. Characterized regulation of gHV68 v-cyclin expression. Aim 3. Define the structural and biochemical basis of differences in the functions of the gHV68 v-cyclin and host D and E type cyclins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of MHV68 v-cyclin in virus egress
-
批准号:8807186
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2014
-
负责人:SAMUEL H SPECK
-
依托单位:
Co-infection of mice with MHV68 and rodent Plasmodium species
-
批准号:8285405
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2012
-
负责人:SAMUEL H SPECK
-
依托单位:
Co-infection of mice with MHV68 and rodent Plasmodium species
-
批准号:8416962
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2012
-
负责人:SAMUEL H SPECK
-
依托单位:
Role of gammaHV68 M1 antigen in Vbeta4+ T cell expansion and fibrosis
-
批准号:8010967
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:SAMUEL H SPECK
-
依托单位:
Role of gammaHV68 M1 antigen in Vbeta4+ T cell expansion and fibrosis
-
批准号:7387671
-
项目类别:
-
资助金额:$43.14万
-
财政年份:2008
-
负责人:SAMUEL H SPECK
-
依托单位:
Role of gammaHV68 M1 antigen in Vbeta4+ T cell expansion and fibrosis
-
批准号:8204743
-
项目类别:
-
资助金额:$39.08万
-
财政年份:2008
-
负责人:SAMUEL H SPECK
-
依托单位:
Role of gammaHV68 M1 antigen in Vbeta4+ T cell expansion and fibrosis
-
批准号:7545503
-
项目类别:
-
资助金额:$38.72万
-
财政年份:2008
-
负责人:SAMUEL H SPECK
-
依托单位:
Role of gammaHV68 M1 antigen in Vbeta4+ T cell expansion and fibrosis
-
批准号:7749544
-
项目类别:
-
资助金额:$39.08万
-
财政年份:2008
-
负责人:SAMUEL H SPECK
-
依托单位:
FUNCTION OF THE GAMMAHV68 M2 ANTIGEN
-
批准号:7349211
-
项目类别:
-
资助金额:$4.01万
-
财政年份:2006
-
负责人:SAMUEL H SPECK
-
依托单位:
ROLE OF B CELLS IN MURINE GAMMAHERPES -68 LATENCY
-
批准号:7349210
-
项目类别:
-
资助金额:$4.01万
-
财政年份:2006
-
负责人:SAMUEL H SPECK
-
依托单位:
REGULATION OF EBV TRANSCRIPTION IN BURKITT'S LYMPHOMA
-
批准号:7349162
-
项目类别:
-
资助金额:$4.01万
-
财政年份:2006
-
负责人:SAMUEL H SPECK
-
依托单位:
CONTROL OF EBV LYTIC GENE EXPRESSION DURING LATENCY
-
批准号:7349161
-
项目类别:
-
资助金额:$4.01万
-
财政年份:2006
-
负责人:SAMUEL H SPECK
-
依托单位:
VIRAL TRANSCRIPTION IN EBV TRANSFORMED B CELLS
-
批准号:7349181
-
项目类别:
-
资助金额:$4.01万
-
财政年份:2006
-
负责人:SAMUEL H SPECK
-
依托单位:
CHARACTERIZATION OF THE GAMMA HERPES VIRUS HV68 V CYCLIN
-
批准号:7165889
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2005
-
负责人:SAMUEL H SPECK
-
依托单位:
DEVELOPMENT OF A NON HUMAN PRIMATE MODEL FOR CHRONIX EBV INFECTION
-
批准号:7165962
-
项目类别:
-
资助金额:$5.24万
-
财政年份:2005
-
负责人:SAMUEL H SPECK
-
依托单位:
VIRAL TRANSCRIPTION IN EBV TRANSFORMED B CELLS
-
批准号:7165916
-
项目类别:
-
资助金额:$1.54万
-
财政年份:2005
-
负责人:SAMUEL H SPECK
-
依托单位:
ROLE OF B CELLS IN MURINE GAMMAHERPES -68 LATENCY
-
批准号:7165960
-
项目类别:
-
资助金额:$3.08万
-
财政年份:2005
-
负责人:SAMUEL H SPECK
-
依托单位:
CONTROL OF EBV LYTIC GENE EXPRESSION DURING LATENCY
-
批准号:7165890
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2005
-
负责人:SAMUEL H SPECK
-
依托单位:
REGULATION OF EBV TRANSCRIPTION IN BURKITT'S LYMPHOMA
-
批准号:7165891
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2005
-
负责人:SAMUEL H SPECK
-
依托单位:
FUNCTION OF THE GAMMAHV68 M2 ANTIGEN
-
批准号:7165961
-
项目类别:
-
资助金额:$3.08万
-
财政年份:2005
-
负责人:SAMUEL H SPECK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于健康行为改变整合理论的艾滋病感染者自我管理生态圈网络系统构建与初步应用
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:朱志红
-
依托单位:
肠道菌群介导的脱氧胆酸激活S1PR2/NLRP3/IL-1β通路在炎症性肠病合并艰难梭菌感染中的致病机制研究
-
批准号:82372306
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:彭奕冰
-
依托单位:
牙周炎对腹主动脉瘤的作用和机制研究
-
批准号:82370953
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:朱亚琴
-
依托单位:
基于质谱贴片的病原菌标志物检测及伤口感染诊断应用
-
批准号:82372148
-
项目类别:面上项目
-
资助金额:60.00万元
-
批准年份:2023
-
负责人:黄琳
-
依托单位:
DNA糖苷酶OGG1调节PARP1介导的EB病毒潜伏蛋白表达的机制研究
-
批准号:32000546
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:郝文静
-
依托单位:
结核分枝杆菌感染巨噬细胞后自噬相关LncRNA分子的筛选及其调控机制研究
-
批准号:31760326
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2017
-
负责人:邓光存
-
依托单位:
基于反式互补的新型丙型肝炎病毒细胞感染模型的建立及其在丙肝研究中的应用
-
批准号:31170149
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:钟劲
-
依托单位:
microRNA对机体抗病毒固有免疫应答RIG-I信号途径的调控作用及机制研究
-
批准号:31170826
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2011
-
负责人:侯晋
-
依托单位:
丙型肝炎病毒感染宿主细胞的分子生物学研究
-
批准号:30870127
-
项目类别:面上项目
-
资助金额:40.0万元
-
批准年份:2008
-
负责人:钟劲
-
依托单位: